IL2 and chronic myelogenous leukemia, BCR-ABL1 positive: This proliferation experiment was also run with cells from another four CML patients that were either Sokal intermediate risk patients or accelerated phase patient similar results in proliferation and IL-2 secretion was seen for these patients (data not shown).